Fig. 13 | Scientific Reports

Fig. 13

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 13The alternative text for this image may have been generated using AI.

Effects of cilazapril and benazepril on the 6-OHDA-induced increase in the IL-1β level. (a) Cilazapril suppressed the increase in IL-1β in a dose-dependent manner, and the IL-1β levels in the S-2.56 and S-5.12 groups decreased to values close to those in the control group (*p < 0.05). (b) Benazepril also significantly decreased the IL-1β level, especially in the B-0.32 and B-0.64 groups (*p < 0.05).

Back to article page